A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non‐small cell lung cancer (LOGIK1902).

Autor: Harada, Taishi¹ (AUTHOR) shiitadaraha@gmail.com, Sasaki, Tomonari² (AUTHOR), Ishii, Hidenobu³ (AUTHOR), Takemoto, Shinnosuke⁴ (AUTHOR), Hisamatsu, Yasushi⁵ (AUTHOR), Saito, Haruhiro⁶ (AUTHOR), Yoneshima, Yasuto⁷ (AUTHOR), Komiya, Kazutoshi⁸ (AUTHOR), Kashiwabara, Kosuke⁹ (AUTHOR), Naoki, Katsuhiko¹⁰ (AUTHOR), Ogawa, Tomohiro¹¹ (AUTHOR), Takeoka, Hiroaki¹² (AUTHOR), Saruwatari, Koichi¹³ (AUTHOR), Ito, Kensaku¹⁴ (AUTHOR), Tsuchiya‐Kawano, Yuko¹⁵ (AUTHOR), Mizuno, Keiko¹⁶ (AUTHOR), Shimose, Takayuki¹⁷ (AUTHOR), Shioyama, Yoshiyuki¹⁸ (AUTHOR), Okamoto, Isamu⁷ (AUTHOR)

Publikováno v: Thoracic Cancer. Oct2024, Vol. 15 Issue 29, p2128-2135. 8p.

A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)

Autor: Wakuda, Kazushige, Yamaguchi, Hiroyuki, Kenmotsu, Hirotsugu, Fukuda, Minoru, Ito, Kentaro, Tsuchiya-Kawano, Yuko, Tanaka, Kentaro, Harada, Taishi, Nakatani, Yuki, Miura, Satoru, Yokoyama, Toshihide, Nakamura, Tomomi, Izumi, Miiru, Nakamura, Atsushi, Ikeda, Satoshi, Takayama, Koichi, Yoshimura, Kenichi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Sugio, Kenji

Publikováno v: In JTO Clinical and Research Reports December 2023 4(12)

TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study

Autor: Katayama, Yuki, Yamada, Tadaaki, Morimoto, Kenji, Fujii, Hiroyuki, Morita, Satomi, Tanimura, Keiko, Takeda, Takayuki, Okada, Asuka, Shiotsu, Shinsuke, Chihara, Yusuke, Hiranuma, Osamu, Yamada, Takahiro, Ota, Takahiro, Harada, Taishi, Hasegawa, Isao, Yoshimura, Akihiro, Iwasaku, Masahiro, Tokuda, Shinsaku, Kim, Young Hak, Takayama, Koichi

Publikováno v: In JTO Clinical and Research Reports April 2023 4(4)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II): A Single-Arm, Open-Label, Phase 2 Clinical Trial

Autor: Hibino, Makoto, Hiranuma, Osamu, Takemura, Yoshizumi, Katayama, Yuki, Chihara, Yusuke, Harada, Taishi, Fujita, Kohei, Kita, Toshiyuki, Tamiya, Nobuyo, Tsuda, Takeshi, Shiotsu, Shinsuke, Tamura, Yukihiro, Aoyama, Takashi, Nakamura, Yoichi, Terashima, Masaaki, Morimoto, Yoshie, Nagata, Kazuhiro, Yoshimura, Kenichi, Uchino, Junji, Takayama, Koichi

Publikováno v: In JTO Clinical and Research Reports December 2022 3(12)